Aravinthan Aloysious, Gelson William, Limbu Anita, Brais Rebecca, Richardson Paul
Aloysious Aravinthan, William Gelson, Anita Limbu, Department of Hepatology, Cambridge University Hospitals NHS Trust, Cambridge CB2 0QQ, United Kingdom.
World J Hepatol. 2012 Dec 27;4(12):402-5. doi: 10.4254/wjh.v4.i12.402.
Hepatic sarcoidosis is usually asymptomatic but rarely leads to adverse liver-related outcome. Co-existence of viral hepatitis and hepatic sarcoidosis is a rare, but recognised phenomenon. Obtaining a balance between immune suppression and anti-viral therapy may be problematic. Immunosuppression in the presence of viral hepatitis can lead to rapid deterioration of liver disease. Similarly, anti-viral therapy may exacerbate granulomatous hepatitis. Here we present two cases of viral hepatitis co-existing with sarcoidosis that illustrate successful management strategies. In one, hepatitis B replication was suppressed with oral anti-viral therapy before commencing prednisolone. In the second, remission of hepatic sarcoidosis was achieved with prednisolone, before treating hepatitis C and obtaining a sustained virological response with pegylated interferon and ribavirin therapy.
肝结节病通常无症状,但很少导致肝脏相关不良后果。病毒性肝炎与肝结节病并存是一种罕见但已被认识到的现象。在免疫抑制和抗病毒治疗之间取得平衡可能存在问题。在病毒性肝炎存在的情况下进行免疫抑制可导致肝病迅速恶化。同样,抗病毒治疗可能会加重肉芽肿性肝炎。在此,我们报告两例病毒性肝炎与结节病并存的病例,阐述了成功的治疗策略。其中一例,在开始使用泼尼松龙之前,通过口服抗病毒治疗抑制了乙型肝炎病毒复制。另一例,在治疗丙型肝炎并通过聚乙二醇干扰素和利巴韦林治疗获得持续病毒学应答之前,使用泼尼松龙使肝结节病得到缓解。